TipRanks
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (DE:2TZ)
FRANKFURT:2TZ
Germany Market

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (2TZ) Income Statement

0 Followers

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Income Statement

Last quarter (Q2 2026), Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's total revenue was ¥936.73M, a decrease of -21.63% from the same quarter last year. In Q2, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's net income was ¥220.32M. See Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 4.92B¥ 7.31B¥ 8.22B¥ 8.25B¥ 6.91B
Gross Profit
¥ 3.64B¥ 3.52B¥ 3.62B¥ 3.29B¥ 2.76B
Operating Expenses
¥ 1.15B¥ 953.99M¥ 2.49B¥ 2.57B¥ 2.14B
Depreciation and Amortization
¥ 115.66M¥ 125.94M¥ 133.15M¥ 120.67M¥ 117.79M
EBITDA
¥ 2.61B¥ 2.74B¥ 1.26B¥ 1.11B¥ 991.28M
Operating Income
¥ 2.49B¥ 2.57B¥ 1.10B¥ 980.05M¥ 866.68M
Other Income/Expenses
¥ -2.14M¥ 12.06M¥ -1.61M¥ 138.80K¥ 6.13M
Pretax Income
¥ 2.49B¥ 2.58B¥ 1.10B¥ 980.19M¥ 872.81M
Net Income
¥ 2.13B¥ 2.23B¥ 986.71M¥ 861.79M¥ 769.14M
Per Share Metrics
Basic EPS
¥ 2.77¥ 2.90¥ 1.28¥ 1.12¥ 1.00
Diluted EPS
¥ 2.77¥ 2.90¥ 1.28¥ 1.11¥ 1.00
Weighted Average Shares Outstanding
769.32M 768.87M 770.87M 768.87M 768.87M
Weighted Average Shares Outstanding (Diluted)
769.32M 768.87M 770.87M 776.39M 768.87M
Currency in CNY

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Earnings and Revenue History